Aberration in microRNA (miRNA) expression or DNA methylation is a causal factor for polycystic ovarian syndrome (PCOS), a common endocrine disorder and leading cause of infertility. However, the epigenetic interactions between miRNA and DNA methylation remain unexplored in PCOS. In this study, we conducted an integrated analysis of RNA-seq, miRNA-seq and MBD-seq on ovarian granulosa cells of PCOS and control groups to reveal the epigenetic interactions involved in the pathogenesis of PCOS. Firstly, we identified 830 genes and 30 miRNAs that were expressed differently in PCOS, and seven miRNAs were found to negatively regulate targeted mRNA expression. Next, in total, 130 miRNAs were found to be significantly differently methylated in promoter regions, while 13 were found to be associated with miRNA expression. Furthermore, the promoter hypermethylation of miR-429, miR-141-3p, and miR-126-3p was proven to suppress miRNA expression and therefore upregulate their corresponding genes, including XIAP, BRD3, MAPK14 and SLC7A5. Our results demonstrate that DNA methylation regulates miRNA expression and therefore controls its corresponding gene expression. The reactivation of the transcription of epigenetically silenced genes may be one of the key elements in PCOS pathogenesis. Meanwhile, the epigenetic mechanisms underlying the regulation of miRNA expression can provide a potential therapeutic target for PCOS in the future. epigenetic modifications in the regulation of gene expression. MiRNAs are small noncoding RNAs acting as post-transcriptional negative regulators of gene expression, which are involved in the regulation of various diseases such as diabetes, insulin resistance, inflammatory disease, and cancer. Meanwhile, aberrant DNA methylation manifests in both global genome stability preservation and in localized gene promoter changes, which influences the transcription of disease-causing genes [7] .
Introduction
Polycystic ovarian syndrome (PCOS) is one of the most prevalent endocrine disorders with the symptoms of hyperandrogenism, chronic anovulation, and polycystic ovaries [1] . It is also considered to be a common cause of body malfunction in women, with symptoms including hirsutism, acne, obesity, menstrual dysfunction, and infertility. It also appears to be associated with an increased risk of metabolic aberrations, including insulin resistance and hyperinsulinism, type 2 diabetes mellitus, dyslipidemia, cardiovascular disease, and endometrial carcinoma [2, 3] .
Ovarian granulosa cells (GCs) have been demonstrated to play a major role in deciding the fate of follicles. In the early stage of follicle development, oocyte apoptosis results in follicular atresiainduced ambient GC death, which results in molecules that are essential for oocyte development and maintenance as well as self-renewal by apoptotic processes [4, 5] . Therefore, it is important to investigate the role of GCs in the pathogenesis of PCOS.
Current research has shown that the influence of multiple factors, including age, the environment/lifestyle, and the disease state environment, can modify the clinical presentation of PCOS via epigenetic modifications [6] . DNA methylation and microRNAs (miRNAs) are two main
Total RNA and genomic DNA extraction
TRIzol (Invitrogen, Waltham, Massachusetts, USA) was used to extract total RNA from GC samples following the manufacturer's protocol. The total RNA quantity was determined with Nanodrop 2000 (Thermo Scientific, Waltham, Massachusetts, USA) and quality was assessed by performing 1% agarose gel electrophoresis, stained using with 4S Red Plus Nucleic Acid Stain (Sango, Shanghai, China).
Genomic DNA from GCs of PCOS patients and normal women was isolated by using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) as recommended by the manufacturer.
Transcriptome sequencing and data analysis
One microgram of total RNA was used to construct the RNA-seq libraries by the KAPA Stranded RNA-Seq Library Preparation Kit (KAPA Biosystem, Wilmington, Massachusetts, USA). The quality of libraries was assessed with Agilent 2100 Bioanalyzer (Agilent, United States). Sequencing reads were aligned to the UCSC Human Genome Browser hg38 assembly with HISAT2 (version 2.0.5), after data preprocessing [16] . Stringtie (version 1.3.3) was then used to determine the read counts per gene based on Ensembl gene-level annotations from Gencode release 31 (GRCh38.p12) [17] . The final unnormalized counts were assembled into a count-matrix with R (version 3.6.0), and this served as an input for DESeq2 (version 1.24.0) and edgeR (version 3.26.5) [18, 19] . In this study, the intersections of differentially expressed genes (DEGs) identified by DESeq2 and edgeR were used for further analysis, and expression changes with absolute value of |log2 fold changes| ≥ 1 and p values < 0.05 were considered significant.
Small RNA sequencing and data analysis
One microgram of total RNA was used to construct the small RNA-seq libraries by the TruSeq® Small RNA Library Prep Kit (NEB, San Diego, California, USA) following the manufacturer's protocol. The quality of libraries was assessed with Agilent 2100 Bioanalyzer (Agilent, United States). Briefly, after trimming the adaptor sequences and filtering low-quality reads, all the clean reads were aligned against miRBase (version 22.1) using bowtie2 (version 2.1.0) [20, 21] . Read counts were then calculated through a customized script. In this study, the intersections of differentially expressed miRNA (DEmiRs) identified by DESeq2 and edgeR were considered significant, and expression changes with absolute values of |log2 fold changes| ≥1, RPM ≥0.1 and p values <0.05 were considered significant. The target genes of DEmiRs were predicted with the miRTarbase database (Release 7.0) and used for further analysis [22] . Then, functional analysis was performed by clusterProfiler as mentioned above [23] .
PPI network analysis of DEGs and DEmiRs
Based on target genes of the previously predicted DEmiRs, the protein-protein interaction network (PPI) network of DEG/DEmiR pairs was built with the STRING database (version 11.0) [24] . Cytoscape (version 3.6.0) was used to visualize the network [25] .
MBD sequencing and bioinformatics analysis
Genomic DNA was fragmented with M220 Focused-ultrasonicator (Covaris, Woburn, Massachusetts, USA). The fragmented DNA with methylated CpGs (mCpG) were enriched using the MethylMiner™ Kit (Invitrogen, Waltham, Massachusetts, USA) as recommended by the manufacturer. The MBD-enriched fractions were used to generate indexed libraries with the NEBNext Ultra DNA Library Prep Kit for Illumina(NEB, San Diego, California, USA) as recommended by the manufacturer. The quality of libraries was assessed with Agilent 2100 Bioanalyzer (Agilent, United States).
MBD-seq raw data reads and filtered low-quality reads were mapped to the reference genome (Human hg38) using bowtie2 [20] . The MEDIPS analysis package (version 1.24.0) was used for the analysis and comparison of DNA methylation datasets of PCOS and controls [26] . P values <0.05 and |log2 fold changes| ≥1 were considered to show differentially methylated regions. Raw sequence data of MBD-seq were submitted to the GEO database and represented under one super-series along with transcriptome sequencing and small RNA sequencing data (Accession Number: GSE138575).
Methylation analysis of promoter region of miRNA associated with miRNA target gene expression
The transcription start site (TSS) data of DEmiRs were extracted from the FANTOM5 database, and 100 bp upstream and downstream were considered to be promoter regions of DEmiRs [27] . The identified differentially methylated miRNA promoter regions from the MBD-seq data were defined as differentially methylated promoters (DMPs).
Validation of the DEGs and DEmiRs expression by qRT-PCR
Five hundred nanograms of total RNA was used for reverse transcription by using the PrimeScript RT Master Mix (TAKARA), which contained a mixture of random 6-mers and oligo dT primer. Additionally, 500 ng of total RNA was used for reverse transcription using SuperScript II Reverse Transcription (Thermo Scientific, Waltham, Massachusetts, USA) with miRNA-specific stem loop primers. Quantitative real-time PCR (qRT-PCR) was then carried out with a PowerUp SYBR Green Master Mix (Applied biosystems) at the StepOne Plus qPCR instrument (Applied Biosystems). Primer sequences are shown in Table S1 .
Statistical analysis
Statistical analyses were conducted by using Statistical Package for Social Sciences (SPSS) version 20.0 software (IBM Corp., Armonk, NY, USA). The differences between groups were assessed by a two-sided Student's t-test, and p < 0.05 was considered statistically significant.
Results

Comparison of clinical data between PCOS patients and normal women
The clinical data including age, height, weight, circumference and serum levels of seven sex hormones-follicle-stimulating hormone (FSH), estrogen (E2), progesterone (P), prolactin (PRL), luteinizing hormone (LH), testosterone (T) and human chorionic gonadotropin β (β-HCG)-are shown in Table 1 . The PCOS patients showed significantly higher body mass indexes (BMI) and increased levels of luteinizing hormone (LH) compared to normal women (p < 0.05). No significant difference was found for other features. The GCs of the above-mentioned PCOS and normal women were then obtained and used for subsequent experiments, as the graphic workflow in Figure 1 showed. All data are presented as the mean ± SEM. p < 0.05 was considered significant. BMI, body mass index; W, waist circumference; H, hip circumference; FSH, follicle stimulating hormone; E2, estrogen; P, progesterone; PRL, prolactin; LH, luteinizing hormone; T, testosterone; β-HCG, human chorionic gonadotropin β. 
Identification of DEGs in GCs between PCOS patients and controls
To determine the significant genes in PCOS patients, the transcriptome profiles of GCs from three PCOS and three control women were sequenced and analyzed. Detailed information regarding the sequencing data is summarized in Table S2 . In order to better identify DEGs, the intersection of two different identification methods, DESeq2 and edgeR, was used as the final dataset (Table S3 ). The hierarchical clustering result indicated the significantly different expression patterns between GCs from PCOS and normal women ( Fig. 2A ). In total, 830 genes were found to be DEGs, including 538 upregulated genes and 292 downregulated genes in PCOS vs. normal GCs ( Fig. 2B and 2C ). Moreover, we tested the reliability of transcriptome sequencing results by using qRT-PCR, and the results demonstrated a high consistency in the randomly selected five genes' (three upregulated and two downregulated genes) expression between RNA sequencing data and qRT-PCR ( Figure 2D ). 
Identification of DEmiRs in GCs between PCOS patients and controls
Small RNA libraries were constructed to identify miRNA expression differences between the GCs of PCOS and normal women. A total of 23,447,261 and 21,642,858 clean reads which mapped to the genome were acquired from PCOS and normal GCs, respectively (Table S2 ). We identified 30 significant DEmiRs (Table S4 ) and performed hierarchical clustering to show the separate miRNA expression patterns between GCs from PCOS and normal women ( Figure 3A ). Based on the intersection of two different identification methods, eight miRNAs were upregulated and 22 were downregulated significantly in PCOS GCs ( Figure 3B and 3C ). In addition, the results of small RNA sequencing (three upregulated and two downregulated miRNAs) were validated by qRT-PCR to prove the reliability of this method ( Figure 3D ). Then, to characterize the regulatory roles of DEmiRs, the potential miRNA target genes were predicted (Table S5 ). Among the 312 predicted target genes, PTEN, BCL2, HIF1A, CDKN1A and DNMT1 had the highest count of potential regulatory miRNAs. Moreover, we analyzed the regulatory function of DEmiRs by using the Gene Ontology (GO) database and Kyoto Encyclopedia of Genes and Genomes (KEGG). Certain GO terms were significantly enriched in the biological process, such as cellular response to different stimuli, stress-activated protein kinase signaling cascade (GO: 0031098), stress-activated MAPK cascade (GO: 0051403), hormone response, response to steroid hormone (GO: 0048545), and response to peptide (GO: 1901652) ( Figure 3E ). In addition, the results of the KEGG analysis indicated that the putative target genes of DEmiRs were involved in the FoxO signaling pathway, the AGE-RAGE signaling pathway in diabetic complications, PI3K-Akt signaling pathway, cellular senescence, and the MAPK signaling pathway ( Figure 3F ). 
Identification of the DEmiRs that negatively regulated targeted mRNA expression
To illustrate the regulatory functions of the miRNAs in PCOS, we found 10 pairs of miRNA and genes which had a significant negative correlation in expression, respectively, with the identified 830 DEGs and 30 DEmiRs ( Table 2 ). In order to further investigate the role of miRNA-gene pairs in PCOS, a miRNA-gene interaction network was then constructed by Cytoscape (Figure 4 ). The network consists of six paired miRNA-gene and 47 DEGs genes that were highly aggregated in interaction network. As demonstrated in Figure 4 , the DEGs in interaction with each other were associated with several downstream pathways, such as the NOD-like receptor signaling pathway, MAPK signaling pathway, interleukin (IL)-17 signaling pathway, tumor necrosis factor (TNF) signaling pathway, PI3K-Akt signaling pathway, nuclear factor (NF)-kappa B signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Th17 cell differentiation, Toll-like receptor signaling pathway and the chemokine signaling pathway. Furthermore, the upregulation of miR-100-3p and miR-196a-5p was involved in the downstream pathways by inhibiting the expression of respective target genes CXCL8 and S100A9. Additionally, four down-regulated miRNAs participated in the regulation of downstream pathways by reducing the transcription repression of target genes including miR-141-3p/MAPK14, miR-144-5/RUNX1, miR-18a-5p/RUNX1 and miR-429/XIAP. 
Log2FC (miRNA), miRNA expression change between GCs of PCOS patients and normal women (PCOS GCs vs Normal GCs); Log2FC (Gene), gene expression change between GCs of PCOS patients and normal
women (PCOS GCs vs Normal GCs). 
Identification of DEGs in GCs between PCOS patients and controls
Aberrant DNA methylation of the miRNA promoter region directly regulates the expression of miRNA. To determine the global methylation pattern of miRNA promoter region in PCOS, we assessed the methylation levels and genomic distribution of both hypomethylated and hypermethylated miRNA promoter regions of 130 miRNA and found that they were significantly differently methylated (Table S6 ). As shown in Figure 5A , we observed a significant hypermethylation of global miRNA promoter regions in PCOS GCs, as 10 DMPs (7.69%) were hypomethylated and 120 DMPs (92.3%) were hypermethylated. In addition, the majority of hypermethylated DMPs were found to be located in chromosome 14 and chromosome X.
Then, a function analysis was performed on 719 predicted target genes of the aforementioned 130 miRNAs to understand the biological significance of the miRNAs with hypermethylated promoters in PCOS patients (Table S7 ). We found that the hypermethylated DEmiRs were mostly involved in the regulation of cell proliferation, development and stimuli response, such as epithelial cell proliferation (GO: 0050673), gland development (GO: 0048732) and response to peptide (GO: 1901652). Additionally, KEGG analysis results showed over-represented biological processes including the PI3K-Akt signaling pathway, FoxO signaling pathway and MAPK signaling pathway. 
Next, we examined the interactions between miRNA and DNA methylation; 13 miRNA promoter methylation interactions that were significantly associated with expression were identified and are presented in Table 3 . To further determine the effect of the interaction between DMPs and DEmiRs on gene expression, we investigated the expression change of promoter aberrant methylated DEmiRs target genes. We found three DEmiRs with DMP were associated with target gene expression levels. As demonstrated in Figure 6A , the promoter region of miR-429, miR-141-3p and miR-126-3p were significantly hypermethylated in PCOS GCs compared to normal controls. Subsequently, we validated the relationship between the three DEmiRs with DMP and their target genes using qRT-PCR ( Figure 6B ). The expression of miR-429 and its target gene XIAP were negatively correlated, while the expression patterns of miR-141-3p and its target genes BRD3 and MAPK14 and miR-126-3p and its target gene SLC7A5 were consistent with what we observed in miR-429 and XIAP. The schematic diagram of interactions between the above-mentioned miRNAs and methylation associated with target gene expression is presented in Figure 6C . 
Discussion
Epigenetic modification regulates gene expression during multiple critical physiological and pathological processes, including cell proliferation, apoptosis, inflammation and carcinogenesis. Among all the epigenetic modifications, DNA methylation and miRNA are both major epigenetic regulators that are reportedly involved in the development of PCOS. Moreover, DNA methylation and miRNA interact with each other and, along with other epigenetic mechanisms, govern the gene expression levels of mRNA and proteins. However, the epigenetic interaction between miRNA and DNA methylation associated with mRNA transcription in PCOS remains unreported.
In the present study, we performed RNA-seq and found 830 DEGs in GCs of PCOS patients, with 538 (64.82%) upregulated and 292 (35.18%) downregulated (Figure 2 ). Using small RNA sequencing, 30 DEmiRs was identified, including eight (26.67%) upregulated and 22 (73.33%) downregulated miRNAs, and 312 target genes of DEmiRs were predicted using the miRTarbase database (Figure 3) . The GO terms of DEmiRs target genes were significantly enriched in biological processes such as cellular response to different stimuli, the cascade of stress-activated protein kinase (SAPK), and mitogen-activated protein kinase (MAPK), which participate in modulating processes such as inflammation and immune activation, development, and apoptosis [28, 29] .
Moreover, among the 312 predicted corresponding genes, 22 were identified as significantly differentially expressed based on transcriptome profiles, and the expression of nine genes was negatively regulated by seven miRNAs ( Table 2 ). For example, there was a negative correlation between miR-141-3p (downregulation) and two genes, BRD3 (upregulation) and MAPK14 (upregulation), respectively. Also, there were two miRNAs, miR-144-5p (downregulation) and miR-18a-5p (downregulation), targeting the same gene, RUNX1 (upregulation), in PCOS. To further illustrate the regulatory functions of negatively regulated PCOS-related DEGs and DEmiRs, we constructed a PPI network with Cytoscape ( Figure 4) . The results illustrated that miR-100-3p (upregulation)/ CXCL8 (downregulation), miR-196a-5p (upregulation)/ S100A9 (downregulation), miR-141-3p (downregulation)/ MAPK14 (upregulation), miR-144-5 (downregulation)/ RUNX1 (upregulation), miR-18a-5p (downregulation)/ RUNX1 (upregulation) and miR-429 (downregulation)/ XIAP (upregulation) compactly participated in the regulation network consisting of 53 identified DEGs. Therefore, these were associated with the NOD-like receptor signaling pathway, MAPK signaling pathway, IL-17 signaling pathway, TNF signaling pathway, PI3K-Akt signaling pathway, NF-kappa B signaling pathway, AGE-RAGE signaling pathway in diabetic complications, Th17 cell differentiation, Toll-like receptor signaling pathway, and chemokine signaling pathway. Among these, the MAPK signaling pathway [30] , PI3K-Akt signaling pathway [31] , and Toll-like receptor signaling pathway [32] had been reported to be involved in PCOS previously by performing apoptosis and cell-proliferation related processes.
Furthermore, we performed MBD-seq to characterize the miRNA promoter methylation pattern in PCOS GCs. Compared to normal women, the majority of DMPs in PCOS were hypermethylated (92.3%) and mainly located in chromosome 14 (48.46%) and chromosome X (30%). In various species, the miRNA distribution pattern is uneven, with miRNA concentrated into certain chromosomes and physically adjacent miRNA genes transcribed as clusters [33] . A previous study reported that certain chromosomes have relatively higher counts of miRNA associated with development and disease processes, such as chromosomes 1, 14, 19, and X [34] . In our study, we found 63 miRNAs with DMPs that are members of the human chromosome 14 microRNA cluster (C14MC), which was reported to control important biological functions in placental and embryonic development [35] . Surprisingly, all aforementioned members of C14MC shared the same hypermethylated promoter region, which is consistent with another study which showed that multiple pre-miRNA transcripts may be produced from the same pre-miRNA cluster. In contrast, the 39 miRNAs localized in chromosome X corresponded to nine different hypermethylated promoter regions (Table S6 ). These observations suggest that underlying epigenetic mechanisms may play an important role in the chromosome 14 and chromosome X-regulated cellular processes in PCOS.
DNA methylation can result in the inhibition of miRNA transcription by hypermethylating the CpG islands in the promoter regions of miRNAs. In this study, we found 12 miRNA silencing events caused by the hypermethylation of the miRNA-coding gene promoter, and one hypomethylation of a miRNA promoter led to its upregulation. Additionally, the DNA methylation of the miRNA promoter region controlling its corresponding gene expression was observed in miR-429, miR-141-3p and miR-126-3p. All four target genes of these miRNAs, XIAP, BRD3, MAPK14 and SLC7A5, were upregulated due to the reduced suppression of miRNA, which is caused by its transcription inhibition resulting from promoter hypermethylation ( Figure 6 ).
MAPK14 and miR-141-3p have both been identified as being related to PCOS. The coding protein of MAPK14 is a member of the mitogen-activated protein (MAP) kinase family and is involved in serval critical biological processes such as cell proliferation, differentiation, and development [29] . Cabergoline (Cb2), one of the dopamine receptor 2 agonists, has been used to reduce the ovarian hyperstimulation risk associated with PCOS, and MAPK14 was shown to be a key gene implicated in these pathways in Cb2 response, which might be a potential biomarker for further studies of PCOS [36] . MAPK14 was also found to participate in the biosynthesis of human androgen, a hormone whose excessive production was mainly induced by PCOS [37] . Likewise, the differential expression of miR-141-3p was reported in rat models of PCOS induced by letrozole, and consistently with our findings, it showed a significantly decreased expression in the PCOS group and regulated the MAPK signaling pathway [38] . Our study further demonstrated the complicated epigenetic mechanism underlying miR-141-3p/MAPK14 regulation in GC function.
In addition, previous studies have also suggested that XIAP and miR-429 are involved in the mechanism of cell apoptosis and anovulation, respectively. Most of the GCs of polycystic ovaries had fundamental and significant differences in the rate of cell death and proliferation and were demonstrated to be more non-apoptotic than GCs of normal follicles [39] . It had previously been reported in another study that the X-linked inhibitor of the apoptosis protein encoded by XIAP was involved in blocking apoptosis by inhibiting caspase-3 activity, and the overexpression of XIAP has been reported in many diseases such as leukemia and breast cancer [40, 41] . On the other hand, miR-429 was found to play an essential role in mammal ovulation. The knockout of miR-429 led to increased ZEB1 expression in the pituitary of mice, resulting in unsuccessful ovulation [42] . Our results suggested roles for miR-429 and its target gene XIAP in the regulation of the GCs of PCOS. Further investigation is needed to determine their specifically regulatory function and potential as biological markers in PCOS.
DNA methylation can result in the inhibition or activation of miRNA transcription by hypermethylating or hypomethylating the CpG islands in the promoter regions of miRNAs. Conversely, miRNAs can also regulate DNA methylation by directly targeting DNA methyltransferases and methylation-related critical proteins, thereby affecting the whole genome methylation pattern [14] . It is worth noting that DNMT1 was predicted to be a target gene of three DEmiRs including miR-126-3p, miR-18a-5p and miR-429. However, the expression data of DNMT1 were not found in our transcriptome profile. It is worth further exploring this to confirm the regulation mechanism of DNA methylation by miRNAs in PCOS.
Previous works had proved that individual epigenetic regulation, especially miRNAs and DNA methylation, played an important role in PCOS. Further investigation of DNA methylation patterns and miRNA expression profiles in PCOS will facilitate the foundation of novel therapeutic strategies and the characterization of suitable diagnostic and prognostic markers. The regulatory roles of epigenetic interactions between miRNA and DNA methylation also require deeper exploration to help improve the understanding of the regulation function of GCs in PCOS.
Conclusions
In conclusion, in this study, we investigated the relevant dysregulation of miRNA expression and methylation in GCs of PCOS. We confirmed that DNA methylation regulated miRNA transcription by hypermethylating the CpG islands in the promoter regions of miRNAs. Moreover, our results indicated that, by suppressing miRNA, DNA hypermethylation inducing the overexpression of miRNA target genes was found in miR-429/XIAP, miR-141-3p/BRD3, miR-141-3p/MAPK14, and miR-126-3p/SLC7A5. The reactivation of the transcription of epigenetically silenced genes may be one of the key elements of PCOS pathogenesis, and the epigenetic mechanisms underlying the regulation of miRNA expression can provide a potential therapeutic target for PCOS in the future. : Table S1 : Primer Sequence, Table S2 : Sequencing data information, Table S3 : Differentially expressed genes, Table S4 : Differentially expressed miRNAs, Table S5 : Predicted target genes of
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